Furthermore, a lower serum IGF-1/IGFBP-3 molar ratio has been connected to poorer executive function in MCI patients, particularly those with type 2 diabetes mellitus (T2DM), suggesting that IGF-1 may play a role in the development of cognitive impairment [138]. The gene discussed is IGFBP3; the disease is type 2 diabetes mellitus.